Related Experiment Video
Updated: Nov 8, 2025

06:52
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
6.7K
Colorectal Cancer Stem Cell States Uncovered by Simultaneous Single-Cell Analysis of Transcriptome and Telomeres
Hua Wang1,2, Peng Gong1,2,3, Tong Chen4
1State Key Laboratory of Medicinal Chemical Biology Nankai University Tianjin 300350 China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|April 26, 2021
Summary
Rare cancer stem cells (CSCs) in colorectal cancer (CRC) are dormant and plastic, linked to cancer epithelial cells (EPCs). CSCs have shorter telomeres and distinct gene signatures, impacting CRC prognosis.
Area of Science:
- Oncology
- Cell Biology
- Genomics
Background:
- Cancer stem cells (CSCs) are implicated in tumor progression and drug resistance.
- Definitive CSC features and their heterogeneity remain incompletely understood.
- Colorectal cancer (CRC) presents a significant challenge due to its complex cellular landscape.
Purpose of the Study:
- To systematically characterize cancer stem cells (CSCs) in primary colorectal cancer (CRC).
- To elucidate the relationship between CSCs, cancer epithelial cells (CEPs), and tumor-initiating cells (TICs).
- To identify molecular features and prognostic markers associated with CSCs.
Main Methods:
- Simultaneous measurement of telomere length and transcriptome in single cells.
- In-depth transcriptome profiling using SMART-seq2.
- Validation via high-throughput single-cell RNA sequencing (scRNA-seq) using 10 × Genomics.
- Analysis of chromosome copy number variation (CNV).
Main Results:
- Rare CSCs identified in a dormant state with plasticity towards cancer epithelial cells (CEPs)/tumor-initiating cells (TICs).
- CSCs and CEPs/TICs share prominent signaling pathways (WNT, TGF-β, HIPPO/YAP).
- CSCs exhibit a distinct CNV pattern from normal stem cells, suggesting a phylogenetic link to CEPs.
- CSCs possess shorter telomeres and minimal telomerase activity, correlating with their nonproliferative state.
- Specific CSC gene signatures (NOTUM, SMOC2, BAMBI, PHLDA1, TNFRSF19) correlate with CRC prognosis.
Conclusions:
- This study provides a detailed characterization of CSC heterogeneity in CRC.
- CSCs are linked to CEPs/TICs, challenging conventional definitions.
- Identified CSC-associated genes serve as potential prognostic biomarkers for colorectal cancer.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
5.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
Replicative Cell Senescence
4.0K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.0K
Cancers Originate from Somatic Mutations in a Single Cell
13.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.4K

